| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Epizyme, Inc. | Senior Vice President, Finance and Corporate Controller | Common Stock, par value $0.0001 | 0 | $1.41 | 12 Aug 2022 | Direct | |
| Epizyme, Inc. | Senior Vice President, Finance and Corporate Controller | Stock Option (Right to Buy) | 0 | $0.5600 | 09 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322028859-beaulieu-joseph-2022-08-12 | Epizyme, Inc. | 12 Aug 2022 | 2 | $0 | 4 | Senior Vice President, Finance and Corporate Controller | 16 Aug 2022, 18:55 |
| /report/000089924322028418-beaulieu-joseph-2022-08-09 | Epizyme, Inc. | 09 Aug 2022 | 3 | +$27,989 | 4 | Senior Vice President, Finance and Corporate Controller | 11 Aug 2022, 20:53 |
| /report/000089924322011728-beaulieu-joseph-2022-03-17 | Epizyme, Inc. | 17 Mar 2022 | 2 | +$2,952 | 4 | Senior Vice President, Finance and Corporate Controller | 21 Mar 2022, 18:06 |
| /report/000089924322005473-beaulieu-joseph-2022-02-07 | Epizyme, Inc. | 07 Feb 2022 | 1 | -$333 | 4 | Corporate Controller | 09 Feb 2022, 16:43 |
| /report/000089924322004826-beaulieu-joseph-2022-02-02 | Epizyme, Inc. | 02 Feb 2022 | 1 | -$941 | 4 | Corporate Controller | 04 Feb 2022, 15:15 |
| /report/000089924321033404-beaulieu-joseph-2021-08-16 | Epizyme, Inc. | 16 Aug 2021 | 2 | $0 | 4 | Corporate Controller | 18 Aug 2021, 08:07 |